Fuki: It's worse than the first time

After taking Pfizer's oral medication, the new crown "Fuyang": The symptoms are worse than the first time

According to a report by the Broadcasting Corporation (ABC) on June 29, after the results of the new crown virus detection were positive earlier this month, Anthony Wudi, the director of the Institute of Infectious Diseases and Infectious Diseases, "Fuyang". He said on Tuesday that after receiving Pfizer's antiviral oral medication treatment, he was experiencing a "symptom rebound". It is reported that more and more Americans are happening.

Fitch (Data Map)

Fuki, the 81 -year -old White House chief medical consultant, said that when his first new coronal virus test was positive two weeks ago, the symptoms were very mild. However, when he started to feel uncomfortable, "considering his age", the doctor gave him Paxlovid Phaju's antiviral oral administration.

Fook said that in addition to fatigue and a bit of nasal obstruction, he felt "really good". After receiving 5 days of Paxlovid treatment, his fast detection results were negative.

However, after 3 consecutive days of testing, in case of it, Foic decided to do another test, and the test results on the fourth day were positive.

"This is a bit like the" Paxlovid rebound "that people call." Fuki said in a remote interview with the Global Health Forum of the US Foreign Policy Magazine on Tuesday. He also mentioned that on the next day, he began to feel "very uncomfortable" and "worse than the first (positive)".

It is reported that Paxlovid, a antiviral oral drug produced by Pfizer, is authorized in the United States to use new crown pneumonia patients with mild to moderate symptoms. These people have a lot of risks to develop into severe illnesses. The phenomenon of "rebound" mentioned by Ficki refers to the recurrence of the symptoms of the new coronary pneumonia within 2-8 days after the recovery of the infection, or the virus test is positive again.

Last month, the US Centers for Disease Control and Prevention (CDC) asked doctors to pay attention to this seemingly rare but more and more reported.

US CDC officials said that the short recurrence of new crown symptoms may be part of the virus "natural history", which occurs mostly on the same group of people, which has nothing to do with whether they have taken PaxLovid or whether they have vaccinated the vaccine.

The report quoted the US CDC that although the information is still limited, the existing data show that most patients who have experienced "rebound" are unlikely to have severe illnesses. There is no evidence that patients need additional PAXLOVID treatment after experiencing "rebound".

The US Food and Drug Administration (FDA) also said, "There is no evidence to indicate a long course of treatment, or duplicate PAXLOVID therapy is good for patients with recurrence of new crown symptoms."

The US CDC currently recommends a new crown patient with "rebound" to follow the quarantine guidance of CDC and take additional preventive measures to prevent virus transmission. Patients with "rebound" should be isolated for at least 5 days. According to the guidance of the agency, if the fever is more than 24 hours and the symptoms are improving, this re -isolation can be ended after 5 days. The agency also suggested that the doctor told patients that after a "rebound", they should wear a mask for 10 days.

- END -